Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Percent.
The item "Debt-To-Capital-Ratio" stands at 26.24 percent as of 06/30/2025, the highest value since 03/31/2024.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Debt To Capital Ratio" stands at 26.24 Percent. This represents an increase of 5.24 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.76 percentage points compared to the value the year prior.
The 1 year change in percentage points is 3.76.
The 3 year change in percentage points is -1.75.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Debt To Capital Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Debt To Capital Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Debt To Capital Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Debt To Capital Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Debt To Capital Ratio | 280,205,508,085.11 |